Bio-Techne Corporation

Bio-Techne Corporation

World Rank (Aug-2026)
1999
Market Cap (Aug-2026)
11.336 Billion USD
World Rank (Jan-05-2024)
1,474
Market Cap (Jan-05-2024)
11.453 Billion USD
World Rank (Jul-30-2023)
1,331
Market Cap (Jul-30-2023)
13.192 Billion USD
World Rank (Jan-07-2022)
1,244
Market Cap (Jan-07-2022)
16.319 Billion USD
World Rank (Jan-01-2021)
1,426
Market Cap (Jan-01-2021)
12.260 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 516
Headquarters Country
USA
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Bio Pharmaceutical Companies in USA
Nasdaq / NYSE Code
TECH
CEO
Charles R. Kummeth
Chairman
Robert V. Baumgartner
Employee Count
3,000
Employee Count as of Date
As on 2022
Headquarters City/State
Minnesota
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
1,215 Million USD
Annual Operating Income in USD
252 Million USD
Annual Net Income in USD
182 Million USD
Annual Results for Period Ending
For year ending June-2026
Total Assets in USD
2,587 Million USD
Total Liabilities in USD
479 Million USD
Total Equity in USD
2,108 Million USD
Balance Sheet for Period Ending
As of June-2026
Business Sector
Healthcare
Biopharmaceutical
Biotechnology
Technology
HealthCare Products
Company Website
Bio-Techne Corporation
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile

BIO-TECHNE CORPORATION is Biotechnology company with headquarters is in Minnesota, USA. It develops, manufactures and sells instruments, for and services research, diagnostics.

BIO-TECHNE CORPORATION total number of employees in 2022 was 3,000, a 15.38% increase from 2021.

BIO-TECHNE CORPORATION annual revenue generated for period ending Jun-2022 was 1,105 Billion USD.

BIO-TECHNE CORPORATION annual net income generated for period ending Jun-2022 was 271 Billion USD.

Total Assets as on Jun-2022 was 2,294 Million USD.

Annual Results Summary

BIO-TECHNE CORPORATION - Annual Results Summary - in Million USD

Year Ending:Total RevenueGross ProfitOperating IncomeNet Income
Jun-20231,136770291285
Jun-20221,105756295271
Jun-2021931632242140
Jun-2020738483149229
Jun-201971447314796
Balance Sheet Summary

Total Assets as on Jun-2023 was 2,638 Million USD.

Total Liabilities as on Jun-2023 was 672 Million USD.

Total Equity as on Jun-2023 was 1,966 Million USD.

Founded Year
1976
Stock Category
S&P 500
Stock Exchange
Frankfurt
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share